Vanguard’s Equity Income fund: a good choice after the Woodford collapse?

Edward Sheldon reviews the Vanguard FTSE UK Equity Income index.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

If you’re looking for a new home for your savings after the collapse of the Woodford Equity Income fund, you may be considering the Vanguard FTSE UK Equity Income index.

This is a low-cost tracker fund that invests in UK dividend-paying companies and sports a bumper yield. Here, I take a closer look at this fund and highlight the risks you need to be aware of.

Investment strategy

The first thing to understand about Vanguard is its investment strategy. A passive fund (meaning there’s no fund manager), it seeks to track the performance of the FTSE UK Equity Income Index – which consists of stocks listed on the London Stock Exchange’s main market that are expected to pay dividends that generally are higher than average.

At 30 September, the fund held 128 stocks, so it’s well diversified. Note, however, the top 10 holdings (below) made up over 40% of the fund, meaning there’s a degree of stock-specific risk.

Source: Vanguard


In terms of yield, this fund’s certainly a winner. At end-September, the yield offered was a bumper 5.2%. By contrast, Vanguard’s FTSE 100 tracker offers a yield of 4.2%. It’s important to remember though that yields fluctuate depending on the dividends paid out by the underlying companies in the index. Dividends are paid out bi-annually and will either be paid in cash or reinvested, depending on whether you invest in the income or accumulation version of the fund.


Another great feature of this fund is its super low cost. Vanguard has recently slashed the fees on many of its funds and, on its website, it advertises this fund with a low ongoing charge of just 0.14%. On Hargreaves Lansdown, however, the fee is still 0.22% (this may be reduced in the near future).


Turning to risks, there are a number of risks you need to be aware of. Firstly, the fund has high exposure to high-yield stocks. Nearly all the stocks in the top 10 holdings yield 5%, or higher.

Now, while this kind of strategy will help the fund generate a high yield, it may not produce brilliant total returns (capital gains plus income) over the long run. Interestingly, the fund has underperformed the market by a wide margin over the last five years, returning around 27%, versus 41% for the FTSE All-Share index. 

Secondly, the fund has a relatively high exposure to the financial sector. At 30 September, financials represented nearly a quarter of the portfolio. If this sector was to underperform on the back of a global recession, the fund’s performance (and its yield) could be impacted negatively.

Finally, with no fund manager at the helm, there’s uncertainty as to how the fund will perform in a major bear market. This fund was launched in June 2009, as markets were recovering from the Global Financial Crisis, so it’s unproven in a major stock market collapse. That’s certainly something to keep in mind.


Overall, given its high yield and low fees, I see this fund as a good choice for those who are looking to generate an income right now, such as those in retirement. If you don’t need the income right now, however, you may be better off in a fund that’s more focused on total returns, in my view.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Edward Sheldon owns shares in Hargreaves Lansdown, Lloyds Bank, and GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended AstraZeneca, Hargreaves Lansdown, HSBC Holdings, and Lloyds Banking Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Asian man drinking coffee at home and looking at his phone
Investing Articles

Is Rolls-Royce’s share price an irresistible bargain?

Is Rolls-Royce's share price the FTSE 100's greatest bargain today? Royston Wild explains why he would -- and wouldn't --…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

Is the Vodafone share price a wonderful bargain or a horrible value trap?

As the Vodafone share price continues to fall, is it now a stock to buy with a view to a…

Read more »

Hand of a mature man opening a safety deposit box.
Investing Articles

I’d buy 95,239 shares of this banking stock to generate £200 of monthly passive income

Muhammad Cheema takes a look at how Lloyds shares, with a dividend yield of 5.9%, can generate a healthy monthly…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

Can FY results give the Antofagasta share price a long-term boost?

The Antofagasta share price has had a good five years. Now the company says it's set to enter a new…

Read more »

Person holding magnifying glass over important document, reading the small print
Dividend Shares

Can I make sustainable passive income from share buybacks?

Jon Smith notes the rise in share buybacks from FTSE 100 companies, but flags up why they aren't great for…

Read more »

Front view of a mixed-race couple walking past a shop window and looking in.
Investing Articles

After the Currys share price rockets, here are more potential UK takeover targets!

The Currys share price has surged 39% higher in response to news of a takeover bid. Which UK stocks could…

Read more »

Investing Articles

Down 25%, where will the British American Tobacco share price go next?

The British American Tobacco share price has taken a hit. But this Fool isn't deterred. He think's now could be…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

2 cheap dividend stocks I’d snap up in a heartbeat!

This Fool is on the look out for quality dividend stocks and earmarks these two firms as great options to…

Read more »